NCT06725693View on ClinicalTrials.gov

Glucagon-like Peptide-1 Receptor PET/CT in GLP-1R Related Disease

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

November 1, 2027

Study Completion Date

November 1, 2027

Conditions
GLP1-R-related DiseaseTumorInsulinomaPositron Emission Tomography
Interventions
DIAGNOSTIC_TEST

18F/68Ga-Exendin 4

Each subject receive a single intravenous injection of 68Ga/18F-Exendin 4, and undergo PET/CT imaging within the specificed time.

Trial Locations (1)

300052

RECRUITING

Tianjin Medical University General Hospital, Tianjin

All Listed Sponsors
collaborator

Tianjin Medical University General Hospital

OTHER

lead

Tianjin Medical University

OTHER